Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 166 clinical trials
Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer

The study is a single center phase II trial. The purpose is to investigate both the efficacy and safety of chemotherapy combined with anti-PD-1 antibody Followed by chemoradiotherapy in locoregionally advanced hypopharyngeal cancer.

absolute neutrophil count
cancer
renal function
measurable disease
carcinoma
  • 0 views
  • 28 Aug, 2021
  • 1 location
GDF15 Based TPF Induction Chemotherapy for OSCC Patients

The purpose of this study is to confirm the predictive value of GDF15 expression for TPF induction in T3/T4cN0M0 patients with OSCC

cancer
induction chemotherapy
caries
docetaxel
external radiation
  • 18 views
  • 25 Feb, 2022
  • 1 location
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

To see the effect if a combination of induction chemotherapy followed by chemoradiotherapy works in treating children with advanced nasopharyngeal carcinoma(NPC).

cancer
platelet count
nasopharyngeal carcinoma
induction chemotherapy
chemoradiotherapy
  • 0 views
  • 15 Feb, 2022
  • 1 location
Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

This is a single-center, multidisciplinary, open-label, single-arm prospective clinical study.

absolute neutrophil count
carcinoma
creatinine clearance rate
chemotherapy regimen
capecitabine
  • 0 views
  • 26 Dec, 2021
  • 1 location
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

This research is being done to assess the therapeutic efficacy and safety of a promising (venetoclax and decitabine) versus conventional "7+3"chemotherapy in induction young patients with acute myeloid leukemia. This study involves the following: Venetoclax and decitabine (investigational combination) Cytarabine and idarubicin (per standard of care)

  • 0 views
  • 13 Mar, 2022
  • 1 location
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (APOLO)

evaluate the efficacy of the treatment (Atezolizumab + Induction chemotherapy (CT) + CT-Radiotherapy) in terms of the Progression Free Survival at 12 months

absolute neutrophil count
serum bilirubin level
cancer chemotherapy
cancer
platelet count
  • 0 views
  • 15 Jun, 2022
  • 22 locations
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy (NPC-GTV)

carcinoma patients treated with induction chemotherapy plus concurrent chemoradiotherapy.

cancer
concurrent radiochemotherapy
nasopharyngeal carcinoma
induction chemotherapy
chemoradiotherapy
  • 0 views
  • 23 Apr, 2022
  • 2 locations
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

The purpose of this study is to To confirm the predictive value of CCND1 for TPF induction in cN2 patients with OSCC

cancer
ccnd1
induction chemotherapy
caries
docetaxel
  • 19 views
  • 24 Feb, 2022
  • 1 location
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

oligometastasis after induction chemotherapy. Half of participants who meet the entry criterion will receive surgical intervention, while the other half will continue to receive standard chemotherapy.

cancer chemotherapy
cancer
liver metastasis
folfirinox
ca19-9
  • 8 views
  • 15 Feb, 2022
Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (INDUCTION)

The benefit of induction chemotherapy followed by chemoradiotherapy for locally advanced head and neck squamous cell carcinoma is unknown. The present study is investigating if this therapeutic

induction chemotherapy
neutrophil count
chemoradiotherapy
histological diagnosis
squamous cell carcinoma
  • 0 views
  • 12 Feb, 2022
  • 1 location